Embolization and chemoembolization for hepatocellular carcinoma

B. Damascelli, F. Garbagnati, A. Marchiano, M. Salvetti, G. Di Tolla, R. Lanocita

Research output: Contribution to journalArticlepeer-review

Abstract

A check on the rationale for embolization and chemoembolization for hepatocellular carcinoma and a revisit to the background of the anatomy of blood supply to the liver is discussed. The technique of the embolization is different and mostly in the range of home made configuration. There is no data concerning the stability of different choices such as the popular mixture of cytotoxic agents and lipiodol. Therefore the authors have preferred the use of microencapsulated Mitomycin believing that this special formulation of the drug can attain the present best reproducibility. The survival of 32 treated patients was longer than the control group. Twelve, 36 and 60 month survival was 70%, 45% and 15% vs 37%, 0%, and 0% respectively.

Original languageEnglish
Pages (from-to)103-104
Number of pages2
JournalItalian Journal of Gastroenterology
Volume24
Issue number2
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Embolization and chemoembolization for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this